Atlas Trials

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Clinical trial NCT05732051 · RECRUITING

Trial details

NCT number
NCT05732051
Sponsor
University Hospital, Akershus
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac DysfunctionCardiotoxicityHeart Failure
Start date
2023-03-16
Primary completion
2025-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.